...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.
【24h】

Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.

机译:药物控制释放:HIV蛋白酶抑制剂的新水溶性前药。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We designed and synthesized a series of highly water-soluble prodrugs of an HIV protease inhibitor, KNI-727 (1), containing tandem-linked two auxiliary units, a solubilizing moiety and a self-cleavable spacer. Prodrugs with an ionized amino group at the solubilizing moiety exhibited a remarkable increase of water-solubility (>10(4) fold) compared to the parent drug 1. These prodrugs released I not enzymatically, but chemically via an intramolecular cyclization-elimination reaction through an imide formation in physiological conditions. Diversified rates of parent drug release were observed when the chemical structure of both the solubilizing and the spacer moieties were modified. This new approach for water-soluble prodrugs will enable to control chemically the release of parent drug as well as to maintain high water-solubility.
机译:我们设计并合成了一系列HIV蛋白酶抑制剂的高水溶性前药KNI-727(1),其中包含串联连接的两个辅助单元,一个可溶部分和一个可自我裂解的间隔子。与母体药物1相比,在可溶部分具有离子化氨基的前药显示出显着的水溶性(> 10(4)倍)。这些前药不是通过酶解而是通过分子内环化消除反应以化学方式释放在生理条件下形成酰亚胺。当增溶部分和间隔部分的化学结构均被修饰时,观察到母体药物释放的多样化速率。这种水溶性前药的新方法将能够化学控制母体药物的释放,并保持高水溶性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号